Parallax Volatility Advisers
GSK icon

Parallax Volatility Advisers’s GSK GSK Stock Holding History

Parallax Volatility Advisers’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,766
Closed -$296K – 1783
2024
Q4 		$296K Buy
+8,766
New +$316K ﹤0.01% 1607
2024
Q1 		– Sell
-64,180
Closed -$2.65M – 2024
2023
Q4 		$2.38M Sell
64,180
-5,875
-8% -$211K ﹤0.01% 1109
2023
Q3 		$2.54M Buy
70,055
+8,363
+14% +$297K 0.01% 1009
2023
Q2 		$2.2M Buy
61,692
+43,259
+235% +$1.55M ﹤0.01% 1102
2023
Q1 		$656K Buy
+18,433
New +$645K ﹤0.01% 1656
2022
Q4 		– Sell
-67,337
Closed -$2.24M – 3033
2022
Q3 		$1.98M Sell
67,337
-12,762,447
-99% -$484M ﹤0.01% 1434
2022
Q2 		$1.53B Buy
+12,829,784
New +$708M 1.46% 13
2021
Q3 		– Sell
-870
Closed -$43.7K – 3163
2021
Q2 		$43K Sell
870
-3,081
-78% -$148K ﹤0.01% 2665
2021
Q1 		$176K Sell
3,951
-5,400
-58% -$245K ﹤0.01% 2712
2020
Q4 		$430K Buy
9,351
+5,129
+121% +$236K ﹤0.01% 2547
2020
Q3 		$199K Buy
4,222
+3,707
+720% +$186K ﹤0.01% 2549
2020
Q2 		$26K Buy
+515
New +$26.4K ﹤0.01% 2560
2020
Q1 		– Sell
-135
Closed -$8K – 2542
2019
Q4 		$8K Buy
+135
New +$7.51K ﹤0.01% 2338
2019
Q3 		– Sell
-9
Closed – – 2769
2019
Q2 		$0 Buy
+9
New +$452 ﹤0.01% 3017
2019
Q1 		– Sell
-3,695
Closed -$185K – 3245
2018
Q4 		$176K Buy
+3,695
New +$182K ﹤0.01% 1776
2018
Q1 		– Sell
-45
Closed -$2.1K – 3040
2017
Q4 		$2K Buy
+45
New +$2.08K ﹤0.01% 3861
2016
Q1 		– Sell
-14,794
Closed -$746K – 2965
2015
Q4 		$746K Buy
+14,794
New +$754K ﹤0.01% 1382
2014
Q1 		– Sell
-36,190
Closed -$2.42M – 3482
2013
Q4 		$2.42M Buy
36,190
+21,245
+142% +$1.38M 0.01% 616
2013
Q3 		$937K Buy
+14,945
New +$962K ﹤0.01% 686

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parallax Volatility Advisers's GSK Position: Q1 2025 in Review

Parallax Volatility Advisers sold out of GSK (GSK) in Q1 2025, closing a stake of 8,766 shares — an estimated $296K sold.

Parallax Volatility Advisers first reported a position in GSK in Q3 2013 and held it in 19 quarters. The position peaked at $1.53B in Q2 2022. 859 funds tracked by Wall St. Rank hold GSK as of Q1 2025.

  • Parallax Volatility Advisers reported no remaining GSK position as of Q1 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 8,766 GSK shares in Q1 2025, an estimated $296K.
  • Parallax Volatility Advisers first reported a position in GSK in Q3 2013 and held it in 19 quarters.
  • Parallax Volatility Advisers's GSK position peaked at $1.53B in Q2 2022.
  • 859 funds tracked by Wall St. Rank held GSK as of Q1 2025.

Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.